Keywords: poniard, starts, ph, oral, picoplatin, study, pharmaceuticals

Poniard starts Ph I oral picoplatin study

Article | 23 April 2007

Print This

Poniard Pharmaceuticals, a US biopharmaceutical company focused on oncology, has announced treatment of the first patient in a Phase I ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in